Daniel De Vos

Daniel De Vos

UNVERIFIED PROFILE

Are you Daniel De Vos?   Register this Author

Register author
Daniel De Vos

Daniel De Vos

Publications by authors named "Daniel De Vos"

Are you Daniel De Vos?   Register this Author

54Publications

-Reads

Guidelines to Compose an Ideal Bacteriophage Cocktail.

Methods Mol Biol 2018 ;1693:99-110

Laboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, Bruynstraat 1, Brussels, 1120, Belgium.

View Article
July 2018

Bacteriophage Production in Compliance with Regulatory Requirements.

Methods Mol Biol 2018 ;1693:233-252

Laboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, Bruynstraat 1, 1120, Brussels, Belgium.

View Article
July 2018

Silk Route to the Acceptance and Re-Implementation of Bacteriophage Therapy-Part II.

Antibiotics (Basel) 2018 Apr 23;7(2). Epub 2018 Apr 23.

GeneCology Research Centre and the Faculty of Science, Health, Education and Engineering, University of the Sunshine Coast, Maroochydore DC, QLD 4558, Australia.

View Article
April 2018

The Magistral Phage.

Viruses 2018 02 6;10(2). Epub 2018 Feb 6.

Federal Agency for Medicines and Health Products, Place Victor Horta 40/40, 1060 Brussels, Belgium.

View Article
February 2018

Stability of bacteriophages in burn wound care products.

PLoS One 2017 27;12(7):e0182121. Epub 2017 Jul 27.

Laboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, Brussels, Belgium.

View Article
October 2017

The Developing World Urgently Needs Phages to Combat Pathogenic Bacteria.

Front Microbiol 2016 8;7:882. Epub 2016 Jun 8.

Laboratory for Molecular and Cellular Technology, Burn Wound Center, Queen Astrid Military Hospital Brussels, Belgium.

View Article
July 2016

A bacteriophage journey at the European Medicines Agency.

FEMS Microbiol Lett 2016 Jan 10;363(2):fnv225. Epub 2015 Dec 10.

P.H.A.G.E., Queen Astrid Military Hospital, Lab. for Molecular and Cellular Technology (LabMCT) Bruynstraat 1, 1120 Brussels, Belgium

View Article
January 2016

Increase of efflux-mediated resistance in Pseudomonas aeruginosa during antibiotic treatment in patients suffering from nosocomial pneumonia.

Int J Antimicrob Agents 2016 Jan 26;47(1):77-83. Epub 2015 Nov 26.

Pharmacologie cellulaire et moléculaire & Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium. Electronic address:

View Article
January 2016

Taking bacteriophage therapy seriously: a moral argument.

Biomed Res Int 2014 29;2014:621316. Epub 2014 Apr 29.

Department of Behavioural Sciences, Royal Military Academy, Renaissancelaan 30, 1000 Brussel, Belgium.

View Article
October 2015

Characterization of newly isolated lytic bacteriophages active against Acinetobacter baumannii.

PLoS One 2014 11;9(8):e104853. Epub 2014 Aug 11.

Laboratory for Molecular and Cellular Technology (LabMCT), Queen Astrid Military Hospital, Brussels, Belgium.

View Article
April 2015

O serotype-independent susceptibility of Pseudomonas aeruginosa to lectin-like pyocins.

Microbiologyopen 2014 Dec 16;3(6):875-84. Epub 2014 Sep 16.

Centre of Microbial and Plant Genetics, University of Leuven, 3001, Heverlee, Belgium.

View Article
December 2014

Experimental phage therapy of burn wound infection: difficult first steps.

Int J Burns Trauma 2014 26;4(2):66-73. Epub 2014 Oct 26.

Burn Wound Center, Queen Astrid Military Hospital Bruynstraat 1, B-1120 Brussel, Belgium.

View Article
October 2014

The deletion of TonB-dependent receptor genes is part of the genome reduction process that occurs during adaptation of Pseudomonas aeruginosa to the cystic fibrosis lung.

Pathog Dis 2014 Jun 16;71(1):26-38. Epub 2014 Apr 16.

Department of Bioengineering Sciences, Research Group Microbiology, Vrije Universiteit Brussel and VIB Structural Biology, Brussels, Belgium; Unit of Microbiology, Expert Group Molecular and Cellular Biology, Institute for Environment, Health and Safety, Belgian Nuclear Research Centre (SCK CEN), Mol, Belgium.

View Article
June 2014

Call for a dedicated European legal framework for bacteriophage therapy.

Arch Immunol Ther Exp (Warsz) 2014 Apr 6;62(2):117-29. Epub 2014 Feb 6.

Laboratory for Molecular and Cellular Technology, Burn Wound Centre, Queen Astrid Military Hospital, Brussels, Belgium,

View Article
April 2014

Stability of Staphylococcus aureus phage ISP after freeze-drying (lyophilization).

PLoS One 2013 2;8(7):e68797. Epub 2013 Jul 2.

Laboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, Brussels, Belgium.

View Article
February 2014

Business oriented EU human cell and tissue product legislation will adversely impact Member States' health care systems.

Cell Tissue Bank 2013 Dec 20;14(4):525-60. Epub 2013 Sep 20.

Human Cell and Tissue Banks, Laboratory for Molecular and Cellular Technology (LabMCT), Queen Astrid Military Hospital, Brussels, Belgium,

View Article
December 2013

Effects of sequential and simultaneous applications of bacteriophages on populations of Pseudomonas aeruginosa in vitro and in wax moth larvae.

Appl Environ Microbiol 2012 Aug 1;78(16):5646-52. Epub 2012 Jun 1.

Department of Zoology, University of Oxford, Oxford, United Kingdom.

View Article
August 2012

Beware of the commercialization of human cells and tissues: situation in the European Union.

Cell Tissue Bank 2012 Aug 21;13(3):487-98. Epub 2012 Jun 21.

Human Cell and Tissue Banks, Laboratory for Molecular and Cellular Technology, Burn Wound Centre, Queen Astrid Military Hospital, Brussel, Belgium.

View Article
August 2012

Evaluation of a microbiological screening and acceptance procedure for cryopreserved skin allografts based on 14 day cultures.

Cell Tissue Bank 2012 Jun 21;13(2):287-95. Epub 2011 Apr 21.

Human Cell and Tissue Banks, Laboratory for Molecular and Cellular Technology, Burn Wound Centre, Queen Astrid Military Hospital, Brussels, Belgium.

View Article
June 2012

Optimizing the European regulatory framework for sustainable bacteriophage therapy in human medicine.

Arch Immunol Ther Exp (Warsz) 2012 Jun 17;60(3):161-72. Epub 2012 Apr 17.

Laboratory for Molecular and Cellular Technology, Burn Wound Centre, Queen Astrid Military Hospital, Brussels, Belgium.

View Article
June 2012

Glycerol treatment as recovery procedure for cryopreserved human skin allografts positive for bacteria and fungi.

Cell Tissue Bank 2012 Mar 1;13(1):1-7. Epub 2011 Mar 1.

Skin- and Keratinocyte Bank, Laboratory for Molecular and Cellular Technology, Burn Wound Centre, Queen Astrid Military Hospital, Brussels, Belgium.

View Article
March 2012

Potential release of aluminum and other metals by food-grade aluminum foil used for skin allograft cryo preservation.

Cell Tissue Bank 2011 Aug 10;12(3):241-6. Epub 2010 Feb 10.

LabMCT, Skin- and Keratinocyte Bank, Burn Wound Centre, Queen Astrid Military Hospital, Brussels, Belgium.

View Article
August 2011

Human cells and tissues: the need for a global ethical framework.

Bull World Health Organ 2010 Nov;88(11):870-2

Skin and Keratinocyte Bank, Burn Wound Centre, Queen Astrid Military Hospital, Bruynstraat 1, B-1120, Brussels, Belgium.

View Article
November 2010

Phage therapy in clinical practice: treatment of human infections.

Curr Pharm Biotechnol 2010 Jan;11(1):69-86

Lab 1, The Evergreen State College, Olympia, WA 98505, USA.

View Article
January 2010

Pseudomonas aeruginosa population structure revisited.

PLoS One 2009 Nov 13;4(11):e7740. Epub 2009 Nov 13.

Laboratory for Molecular and Cellular Technology, Burn Centre, Queen Astrid Military Hospital, Brussel, Belgium.

View Article
November 2009

Distribution and evolution of ferripyoverdine receptors in Pseudomonas aeruginosa.

Environ Microbiol 2009 Aug 21;11(8):2123-35. Epub 2009 Apr 21.

Université de Rouen, Laboratoire M2C, UMR CNRS 6143, groupe microbiologie, Bâtiment IRESE B, UFR des Sciences, 76821 Mont Saint Aignan, France.

View Article
August 2009

Gene polymorphisms of Toll-like and related recognition receptors in relation to the vaginal carriage of Gardnerella vaginalis and Atopobium vaginae.

J Reprod Immunol 2009 Jan 6;79(2):163-73. Epub 2009 Feb 6.

Department of Obstetrics & Gynaecology, Faculty of Medicine & Health Sciences, Ghent University, De Pintelaan 185, B-9000 Ghent, Belgium.

View Article
January 2009

European regulatory conundrum of phage therapy.

Future Microbiol 2007 Oct;2(5):485-91

Hospital Center of the Base-Queen Astrid, Laboratory for Molecular & Cellular Technology, Burn Unit, Bruynstraat 1, B-1120 Neder-over-Heembeek, Belgium.

View Article
October 2007

A review of current and future molecular diagnostic tests for use in the microbiology laboratory.

Methods Mol Biol 2006 ;345:1-21

Microbiology Unit, R&D Diagnostics, INNOGENETICS NV, Gent, Belgium.

View Article
October 2006

Global Pseudomonas aeruginosa biodiversity as reflected in a Belgian river.

Environ Microbiol 2005 Jul;7(7):969-80

Laboratory of Microbial Interactions, Department of Molecular and Cellular Interactions, Flanders Interuniversity Institute of Biotechnology, Vrije Universiteit Brussel, B-1050 Brussels, Belgium.

View Article
July 2005

Analysis of the Pseudomonas aeruginosa oprD gene from clinical and environmental isolates.

Environ Microbiol 2002 Dec;4(12):872-82

Laboratory of Microbial Interactions, Department of Immunology, Parasitology, and Ultrastructure, Flanders Interuniversity Institute of Biotechnology, Brussels Free University, B-1640 Sint-Genesius-Rode, Brussels, Belgium.

View Article
December 2002

Pseudomonas aeruginosa displays an epidemic population structure.

Environ Microbiol 2002 Dec;4(12):898-911

Laboratory of Microbial Interactions, Department of Immunology, Parasitology, and Ultrastructure, Flanders Interuniversity Institute of Biotechnology, Brussels Free University, Paardenstraat 65, B-1640 Sint-Genesius-Rode, Belgium.

View Article
December 2002